Cardiology start-up Acorai has secured $4.5m in an oversubscribed series seed equity round to advance its non-invasive intracardiac pressure monitoring device in clinical trials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,